A Phase 4 interventional study of fresh frozen plasma and prothrombin complex concentrate in Prostate Cancer, Spine, Open and Hip Osteoarthritis, sponsored by Konkuk University Medical Center. Not yet recruiting. Open to participants aged 20 Years to 80 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-01-02.
Sponsored by Konkuk University Medical Center · Phase 4, Interventional, and Treatment
The primary endpoint of this study is the completion time of hemostasis treatment when administered Fresh frozen plasma (FFP) and frozen powder coagulation factor concentrate (PCC) in goal-directed bleeding management for non-cardiac surgery.
7,046 studies on the registry are indexed under Prostatic Neoplasms; 1,580 are open to participants now.
This study's planned enrollment of 154 is above the median of 60 across 5,348 interventional studies indexed under Prostatic Neoplasms.
Browse Prostatic Neoplasms studies →Konkuk University Medical Center is the lead sponsor of 95 studies on the registry; 15 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
according to the Thromboelastography (TEG) test, CK r-time prolongation, fresh frozen plasma transfusion (FFP) is performed
Biological: fresh frozen plasma
according to the Thromboelastography (TEG) test, CK r-time prolongation,prothrombin complex concentrate (PCC) administration
Biological: prothrombin complex concentrate
transfusion of fresh frozen plasma
prothrombin complex concentrate administration
duration from the time diagnosing r-time prolongation to the time achieving bleeding control
Time frame: 1 min
Red Blood Cell amount
Red Blood Cell transfusion amount during surgery
Time frame: 1 hour
FFP amount
FFP transfusion amount during surgery
Time frame: 1 hour
Platelet amount
Platelet transfusion amount during surgery
Time frame: 1 hour
r-time
CK r-time after PCC or FFP
Time frame: 10 min
CRT-MA
CRT-MA after PCC or FFP
Time frame: 10 min
CFF-MA
CFF-MA after PCC or FFP
Time frame: 10 min
Bleeding
Postoperative bleeding amount
Time frame: 6 hour
oxygenation profile
PaO2/FiO2 ratio
Time frame: 1 hour
No study locations are listed for this record.
Plan to share: Undecided
No publications or documents are linked to this record.
This study is not yet recruiting, as verified in Dec 2023. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drug tested here: Prothrombin complex concentrate
Konkuk University Medical Center